Skip to main content
Akso Health Group logo

Akso Health Group — Investor Relations & Filings

Ticker · AHG ISIN · US98422P1084 LEI · 5493007BHBTZESVSIA24 US Human health and social work activities
Filings indexed 190 across all filing types
Latest filing 2024-03-19 Regulatory Filings
Country KY Cayman Islands
Listing US AHG

About Akso Health Group

https://www.ahgtop.com/en/index.html

Akso Health Group operates a social e-commerce platform that collaborates with other domestic e-commerce platforms to offer users a wide selection of products. The company is also developing a new business as a cancer therapy and radiotherapy oncology service provider. This expansion includes plans to open vaccine research centers and radiation oncology centers. These facilities will offer specialized radiation therapy, personalized consultation, conventional treatment planning, and other cancer-related treatment services for patients in need of varying stages of care.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2024
Regulatory Filings Classification · 90% confidence The provided document text appears to be encoded or encrypted and does not contain any readable content, keywords, regulatory headers, or references to specific report types, fiscal periods, or regulatory bodies. Due to the lack of identifiable information and the inability to determine the nature of the document, it cannot be classified into any specific filing category. According to the fallback rule, documents that do not neatly fit into any category should be classified as Regulatory Filings (RNS). The document length is 15,000 characters, which is substantial, but the content is not interpretable.
2024-03-19 English
REPORT OF FOREIGN PRIVATE ISSUER
Capital/Financing Update Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, Akso Health Group, with the SEC. It reports a registered direct offering of American Depositary Shares and warrants, including details of the securities purchase agreement and legal opinion exhibits. The document is 3903 characters long, which is relatively short and primarily announces a financing transaction rather than providing comprehensive financial statements or detailed financial analysis. It does not contain quarterly or annual financial results, nor is it a transcript, governance report, or management discussion. The content focuses on capital raising activities and terms of the offering, which aligns with a Capital/Financing Update. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2024-03-08 English
PROSPECTUS SUPPLEMENT
Capital/Financing Update Classification · 100% confidence The document is a prospectus supplement and accompanying prospectus for a securities offering by Akso Health Group. It details the offering of American Depositary Shares (ADSs) and warrants, including terms, pricing, use of proceeds, risk factors, and legal matters. The document is filed pursuant to Rule 424(b)(5), which is a prospectus supplement filing related to securities offerings. This type of document is a capital markets disclosure related to fundraising and issuance of securities, not a financial report, earnings release, or management discussion. It is not an announcement of a report but the actual offering document. Therefore, it fits the category of Capital/Financing Update (CAP).
2024-03-07 English
REGISTRATION STATEMENT
Capital/Financing Update Classification · 100% confidence The document is a Form F-3 Registration Statement filed with the U.S. Securities and Exchange Commission (SEC) by Akso Health Group. It is a registration statement under the Securities Act of 1933, used for registering securities for public offering. The text includes details about the securities to be offered, the registration process, and legal disclaimers. It is not a financial report, earnings release, or management discussion, but rather a capital markets filing related to fundraising and securities issuance. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it is not merely an announcement of a report but the actual registration statement filing.
2024-02-26 English
REPORT OF FOREIGN PRIVATE ISSUER
Capital/Financing Update Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, Akso Health Group, with the SEC. It reports the closing of a private placement transaction involving the sale of units consisting of ordinary shares and warrants. The document includes details of the securities purchase agreement, the number of shares issued, and the aggregate purchase price. It is a regulatory announcement about a financing event rather than a full financial report or earnings release. The document length is 2736 characters, which is relatively short and focused on a specific capital transaction. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2024-01-29 English
REPORT OF FOREIGN PRIVATE ISSUER
Capital/Financing Update Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, Akso Health Group, with the SEC. It reports the entry into a material definitive agreement, specifically a private placement involving the sale of units consisting of shares and warrants. The document includes details about the securities purchase agreement, terms of the offering, and related exhibits. It is not an annual or quarterly report, audit report, earnings release, or any other financial report type. Instead, it is an update on a capital raising transaction. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is 4364 characters, which is sufficient to contain substantive information about the financing event, not just an announcement or a brief notice.
2024-01-22 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.